unifying technology for life the new safe harbor statement under private securities litigation reform act of 1995 any statements in this presentation that relate to company s expectations are forward looking within meaning since information may involve risks and uncertainties is subject change at time actual results differ materially from expected additional associated with businesses genesis bioventures corgenix can be found periodic filings sec investor 2 24 2004 introduce inc medical corporation brief history companies merger plan combined current fundraising investment structure use proceeds next financing round our vision future york amex gbi founded 1994 subsidiaries biomedical diagnostics llc prion development laboratories 33 interest 26 7 million shares issued r&d strategic focus cancer disease corp nevada otcb conx 1990 public 1998 uk 5 3 operating cardiovascular autoimmunity liver
